Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Director comp.
Credit agrmnt [a]
Appointed director
|
|
Pear Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/07/2021 |
8-K
| Asset disposition, Director compensation was amended/approved, Credit agreement amendment|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of Thimble Point Acquisition Corp",
"Amended and Restated Bylaws of Pear Therapeutics, Inc",
"Amended and Restated Registration Rights Agreement",
"Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Pear Therapeutics, Inc. 2021 Employee Stock Purchase Plan",
"Form of Incentive Stock Option Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Form of Restricted Stock Award Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Form of Restricted Stock Unit Award Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Form of Rollover Incentive Stock Option Agreement under the Pear Therapeutics, Inc. 2021 Stock Option and Incentive Plan",
"Amended and Restated Registration Rights Agreement" |
|
|
|